Cancer vaccine specialist Scancell in PLUS IPO
A company developing a pipeline of cancer vaccines has raised £1.55 million in an initial public offering (IPO) on PLUS.
News
A company developing a pipeline of cancer vaccines has raised £1.55 million in an initial public offering (IPO) on PLUS.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software